Havertown, PA, United States of America

Dana Elaine Moseson

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Reckitt Benckiser Inc., Santarus, Inc.. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dana Elaine Moseson. Retrieved from https://idiyas.com/inventor/dana-elaine-moseson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

 

 

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Havertown, PA (US) (2013 - 2015)
  • Haverton, PA (US) (2013 - 2018)
  • West Lafayette, IN (US) (2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Dana Elaine Moseson: Innovator in Controlled-Release Solid Dosage Forms

Introduction

Dana Elaine Moseson is a notable inventor based in Haverton, PA (US), recognized for her contributions to the field of pharmaceuticals. She holds a total of six patents, showcasing her innovative spirit and dedication to improving patient care.

Latest Patents

Among her latest patents is a significant invention related to controlled-release solid dosage forms of mesalamine. This invention describes capsules that comprise a plurality of coated mini-tablets, designed to treat patients suffering from inflammatory bowel disease. The methods outlined in her patent include administering a therapeutically effective amount of the solid dosage form to patients, with a focus on inducing and maintaining remission of conditions such as ulcerative colitis and Crohn's disease.

Career Highlights

Dana has worked with prominent companies in the pharmaceutical industry, including Reckitt Benckiser Inc. and Santarus, Inc. Her experience in these organizations has contributed to her expertise in developing innovative drug delivery systems.

Collaborations

Dana has collaborated with notable professionals in her field, including Robert Zhong Lu and Steven Wu. These partnerships have likely enhanced her research and development efforts, leading to her successful patent applications.

Conclusion

Dana Elaine Moseson exemplifies the spirit of innovation in the pharmaceutical industry through her work on controlled-release solid dosage forms. Her contributions have the potential to significantly impact the treatment of inflammatory bowel disease, showcasing her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…